Regular prophylaxis with activated prothrombin complex concentrates in pediatric hemophilia.
Ayumi HoriguchiYuki ArakawaYuichi MitaniKiyotaka IsobeMakiko MoriKohei FukuokaKoichi OshimaKatsuyoshi KohPublished in: Pediatrics international : official journal of the Japan Pediatric Society (2024)
Regular prophylactic aPCCs reduced the ABR even in younger children with hemophilia A and B. Serious adverse events include nephrotic syndrome, which requires caution.
Keyphrases